228 related articles for article (PubMed ID: 18388150)
41. The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.
Movérare-Skrtic S; Börjesson AE; Farman HH; Sjögren K; Windahl SH; Lagerquist MK; Andersson A; Stubelius A; Carlsten H; Gustafsson JÅ; Ohlsson C
Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1180-5. PubMed ID: 24395795
[TBL] [Abstract][Full Text] [Related]
42. Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha.
Pace P; Taylor J; Suntharalingam S; Coombes RC; Ali S
J Biol Chem; 1997 Oct; 272(41):25832-8. PubMed ID: 9325313
[TBL] [Abstract][Full Text] [Related]
43. Fulvestrant (ICI 182,780) sensitizes breast cancer cells expressing estrogen receptor alpha to vinblastine and vinorelbine.
Sui M; Jiang D; Hinsch C; Fan W
Breast Cancer Res Treat; 2010 Jun; 121(2):335-45. PubMed ID: 19626437
[TBL] [Abstract][Full Text] [Related]
44. The turnover of estrogen receptor α by the selective estrogen receptor degrader (SERD) fulvestrant is a saturable process that is not required for antagonist efficacy.
Wardell SE; Marks JR; McDonnell DP
Biochem Pharmacol; 2011 Jul; 82(2):122-30. PubMed ID: 21501600
[TBL] [Abstract][Full Text] [Related]
45. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
Trauernicht AM; Kim SJ; Kim NH; Boyer TG
Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
[TBL] [Abstract][Full Text] [Related]
46. Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha.
Preisler-Mashek MT; Solodin N; Stark BL; Tyriver MK; Alarid ET
Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E891-8. PubMed ID: 11882509
[TBL] [Abstract][Full Text] [Related]
47. Cellular and regional distributions of ubiquitin-proteasome and endocytotic pathway components in the epithelium of rat efferent ductules and initial segment of the epididymis.
Oliveira CA; Victor-Costa AB; Hess RA
J Androl; 2009; 30(5):590-601. PubMed ID: 19269934
[TBL] [Abstract][Full Text] [Related]
48. Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.
Kinyamu HK; Archer TK
Mol Cell Biol; 2003 Aug; 23(16):5867-81. PubMed ID: 12897156
[TBL] [Abstract][Full Text] [Related]
49. Evidence for transcriptional activation of ERalpha by IL-1beta in breast cancer cells.
Speirs V; Kerin MJ; Newton CJ; Walton DS; Green AR; Desai SB; Atkin SL
Int J Oncol; 1999 Dec; 15(6):1251-4. PubMed ID: 10568836
[TBL] [Abstract][Full Text] [Related]
50. Differential induction of LRP16 by liganded and unliganded estrogen receptor alpha in SKOV3 ovarian carcinoma cells.
Tian L; Wu Z; Zhao Y; Meng Y; Si Y; Fu X; Mu Y; Han W
J Endocrinol; 2009 Jul; 202(1):167-77. PubMed ID: 19403568
[TBL] [Abstract][Full Text] [Related]
51. Estrogen receptor (ER) expression and function in the pregnant human myometrium: estradiol via ERα activates ERK1/2 signaling in term myometrium.
Welsh T; Johnson M; Yi L; Tan H; Rahman R; Merlino A; Zakar T; Mesiano S
J Endocrinol; 2012 Feb; 212(2):227-38. PubMed ID: 22068927
[TBL] [Abstract][Full Text] [Related]
52. 17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.
Kramer PR; Winger V; Kramer SF
Mol Cell Endocrinol; 2007 Dec; 279(1-2):16-25. PubMed ID: 17923257
[TBL] [Abstract][Full Text] [Related]
53. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells.
Lu IF; Hasio AC; Hu MC; Yang FM; Su HM
J Nutr Biochem; 2010 Jun; 21(6):512-7. PubMed ID: 19369047
[TBL] [Abstract][Full Text] [Related]
54. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
Balan KV; Wang Y; Chen SW; Chen JC; Zheng LF; Yang L; Liu ZL; Pantazis P; Wyche JH; Han Z
Biochem Pharmacol; 2006 Aug; 72(5):573-81. PubMed ID: 16822479
[TBL] [Abstract][Full Text] [Related]
55. Estrogen and hypoxia regulate estrogen receptor alpha in a synergistic manner.
Yi JM; Kwon HY; Cho JY; Lee YJ
Biochem Biophys Res Commun; 2009 Jan; 378(4):842-6. PubMed ID: 19084502
[TBL] [Abstract][Full Text] [Related]
56. Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary.
Alarid ET; Preisler-Mashek MT; Solodin NM
Endocrinology; 2003 Aug; 144(8):3469-76. PubMed ID: 12865327
[TBL] [Abstract][Full Text] [Related]
57. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists.
Barkhem T; Carlsson B; Nilsson Y; Enmark E; Gustafsson J; Nilsson S
Mol Pharmacol; 1998 Jul; 54(1):105-12. PubMed ID: 9658195
[TBL] [Abstract][Full Text] [Related]
58. Estrogen receptor-alpha gene deficiency enhances androgen biosynthesis in the mouse Leydig cell.
Akingbemi BT; Ge R; Rosenfeld CS; Newton LG; Hardy DO; Catterall JF; Lubahn DB; Korach KS; Hardy MP
Endocrinology; 2003 Jan; 144(1):84-93. PubMed ID: 12488333
[TBL] [Abstract][Full Text] [Related]
59. Estrogen receptor α L429 and A430 regulate 17β-estradiol-induced cell proliferation via CREB1.
Pesiri V; Totta P; Segatto M; Bianchi F; Pallottini V; Marino M; Acconcia F
Cell Signal; 2015 Dec; 27(12):2380-8. PubMed ID: 26348925
[TBL] [Abstract][Full Text] [Related]
60. Role of SUMOylation in full antiestrogenicity.
Hilmi K; Hussein N; Mendoza-Sanchez R; El-Ezzy M; Ismail H; Durette C; Bail M; Rozendaal MJ; Bouvier M; Thibault P; Gleason JL; Mader S
Mol Cell Biol; 2012 Oct; 32(19):3823-37. PubMed ID: 22826433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
